Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections
Tirzepatide (Zepbound) Clinical trial data cited by multiple sources, including NBC News, showed average weight loss of approximately 21 to 22.5 percent at the highest dose after 72 weeks, compared with about 3 percent for placebo
Semaglutide, marketed under the brand name Ozempic for diabetes and Wegovy for weight loss, is a once-weekly injectable medication already approved by the FDA for weight management
5 Conclusion In summary, GLP-1RAs have revolutionized obesity and diabetes management, offering potent weight loss and cardiometabolic benefits, but are best used in conjunction with lifestyle interventions, particularly exercise, to optimize health outcomes and sustainability
For blood glucose measurements one drop of blood from the tail vein was collected and analysed using a handheld blood glucose meter (Accu-Chek Aviva)